Diann Dalton Potestio On The Hidden Cost of Waiting
June 17, 2026
Chase leads marketing at RIS Rx, where he advances the company’s leadership in gross-to-net (GTN) revenue protection. His work helps pharmaceutical manufacturers navigate market access complexity and protect GTN performance. Chase holds an AB from Harvard University.
August 13, 2026
May 11, 2026
March 18, 2026
"*" indicates required fields
RIS Rx offers real-time GTN Revenue Protection to the world's leading pharmaceutical manufacturers, ensuring that every dollar allocated for affordability reaches the right patient at the right time.
RIS Rx is pioneering real-time GTN Revenue Protection for the world's leading pharmaceutical manufacturers, ensuring that every dollar allocated for affordability reaches the right patients at the right time.